Cladribine and Pancytopenia - a phase IV clinical study of FDA data
Pancytopenia is found among people who take Cladribine, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Cladribine and have Pancytopenia. It is created by eHealthMe based on reports of 2,076 people who have side effects when taking Cladribine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,076 people reported to have side effects when taking Cladribine.
Among them, 157 people (7.56%) have Pancytopenia.
What is Cladribine?
Cladribine has active ingredients of cladribine. eHealthMe is studying from 2,083 Cladribine users for its effectiveness, alternative drugs and more.
What is Pancytopenia?
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 2,475 drugs and 2,337 conditions by eHealthMe.
Number of Cladribine and Pancytopenia reports submitted per year:
Time on Cladribine when people have Pancytopenia *:
Gender of people who have Pancytopenia when taking Cladribine*:
Age of people who have Pancytopenia when taking Cladribine *:
Common drugs people take besides Cladribine *:
Common side effects people have besides Pancytopenia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cladribine and have Pancytopenia?Check whether Pancytopenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How severe was Pancytopenia and when was it recovered:
Expand to all the drugs that have ingredients of cladribine:
- Pancytopenia and drugs with ingredients of cladribine (167 reports)
Alternative drugs to, pros and cons of Cladribine:
- Cladribine (2,083 reports)
Common Cladribine side effects:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 182 reports
- Drug ineffective: 123 reports
- Febrile neutropenia (fever with reduced white blood cells): 149 reports
- Fever: 156 reports
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 157 reports
- Thrombocytopenia (decrease of platelets in blood): 138 reports
Browse all side effects of Cladribine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pancytopenia treatments and more:
- Pancytopenia (61,604 reports)
COVID vaccines that are related to Pancytopenia:
- Pancytopenia in Moderna COVID Vaccine
- Pancytopenia in Pfizer BioNTech Covid Vaccine
- Pancytopenia in Johnson and Johnson Covid Vaccine
Common drugs associated with Pancytopenia:
All the drugs that are associated with Pancytopenia:
- Pancytopenia (2,475 drugs)
Common conditions associated with Pancytopenia:
All the conditions that are associated with Pancytopenia:
- Pancytopenia (2,337 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cladribine (the active ingredients of Cladribine) and Cladribine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gemzar and Codeine drug interaction - 8 seconds ago
- Contrave and Nerve Injury - 13 seconds ago
- Lazanda and Sinusitis - 22 seconds ago
- Lazanda and Sinusitis - Acute - 22 seconds ago
- Enoxaparin Sodium and Irritability - 35 seconds ago
- Miralax and Echinacea Purpurea drug interaction - 43 seconds ago
- Acitretin and Symbicort drug interaction - 44 seconds ago
- Paxil and Descovy drug interaction - 46 seconds ago
- Levonorgestrel and Cytarabine drug interaction - 48 seconds ago
- Breast Cancer in Citalopram Hydrobromide, how severe and when it was recovered? - 50 seconds ago